US Patent Issued to Exuma Biotech on June 10 for "Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of CD79A and CD79B" (American, Null Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,728, issued on June 10, was assigned to Exuma Biotech Corp. (West Palm Beach, Fla.).

"Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of CD79A and CD79B" was invented by Gregory Ian Frost (West Palm Beach, Fla.), James Joseph Onuffer Jr. (Alameda, Calif.), Ghiabe H. Guibinga (San Diego), Farzad Haerizadeh (San Diego), Frederic Vigant (West Palm Beach, Fla.) and Anirban Kundu (Grand Cayman, Cayman Islands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods and compositions for genetically modifying lymphocytes, for example T cells and/or NK c...